Ad
related to: zynerba pharmaceuticals
Search results
Zynerba Pharmaceuticals, Inc.'s (NASDAQ:ZYNE) Path To Profitability
Simply Wall St. via Yahoo Finance· 1 year agoWith the business potentially at an important milestone, we thought we'd take a closer look at...
Insider Sell: President Terri Sebree Sells 12,401 Shares of Zynerba Pharmaceuticals Inc
GuruFocus.com via Yahoo Finance· 9 months agoOn September 13, 2023, President Terri Sebree of Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) sold...
Zynerba's Cannabidiol Formulated Gel Shows Encouraging Action In Genetic Disease
Benzinga via Yahoo Finance· 2 years agoZynerba Pharmaceuticals Inc (NASDAQ: ZYNE) announced positive top-line results from the Phase 2...
Is Zynerba Pharmaceuticals (NASDAQ:ZYNE) In A Good Position To Deliver On Growth Plans?
Simply Wall St. via Yahoo Finance· 10 months agoWe can readily understand why investors are attracted to unprofitable companies. For example,...
We're Hopeful That Zynerba Pharmaceuticals (NASDAQ:ZYNE) Will Use Its Cash Wisely
Simply Wall St. via Yahoo Finance· 2 years agoEven when a business is losing money, it's possible for shareholders to make money if they buy a...
Zynerba (ZYNE) Upgraded to Buy: What Does It Mean for the Stock?
Zacks via Yahoo Finance· 11 months agoZynerba (ZYNE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the...
UPDATE 2-Zynerba delays genetic disorder drug data on enrollment challenge
Reuters via Yahoo Finance· 1 year agoZynerba Pharmaceuticals Inc on Wednesday delayed the timeline for reporting key data from a trial of its cannabis-based drug to treat a rare genetic disorder, citing difficulties in enrolling ...
Zynerba Pharmaceuticals delays data on genetic disorder drug study
Reuters via Yahoo Finance· 1 year agoDec 21 (Reuters) - Zynerba Pharmaceuticals Inc said on Wednesday it is delaying the timeline for reporting data from a late-stage study of its experimental drug for a genetic disorder due to ...
Zynerba: Q4 Earnings Snapshot
AP Finance via Yahoo Finance· 1 year agoDEVON, Pa. (AP) — DEVON, Pa. (AP) — Zynerba Pharmaceuticals Inc. (ZYNE) on Tuesday reported a loss of $8 million in its fourth quarter. On a per-share basis, the Devon, Pennsylvania-based company ...
20 Countries With Highest Rate of Epilepsy
Insider Monkey via Yahoo Finance· 8 months agoIn this article, we will take a detailed look at the 20 countries with the highest rates of epilepsy with insights into number of epilepsy cases by...
